Taiwan Speciality Chemicals Corporation (4772) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Taiwan Speciality Chemicals Corporation TWD 170, price TWD 245, upside -30.8%, quality 63 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Taiwan Speciality Chemicals Corporation for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
48‑month range 64.53 TWD – 372.01 TWD · fair‑value band 107.56 TWD – 266.70 TWD · the 245.00 TWD price screens above the 169.66 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Taiwan Speciality Chemicals in your weekly email
Every Wednesday you see whether Taiwan Speciality Chemicals is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Taiwan Speciality Chemicals Corporation manufactures and sells precision chemical materials, and specialty electronic-grade gases and chemicals in Taiwan, America, Asia, Northeast Asia (Japan and South Korea), and Europe. It offers electronic grade disilane and trisilane, and related silicon products.
Show more
Taiwan Speciality Chemicals Corporation manufactures and sells precision chemical materials, and specialty electronic-grade gases and chemicals in Taiwan, America, Asia, Northeast Asia (Japan and South Korea), and Europe. It offers electronic grade disilane and trisilane, and related silicon products. The company was founded in 2013 and is based in Changhua, Taiwan.
Stock analysis
Taiwan Speciality Chemicals Corporation (4772) currently trades at 245.00 TWD, while our model-based Fair Value estimate is 169.66 TWD, implying the stock looks roughly 44.4% overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 180.79 TWD per share, and 0 of the 26 models we run sit above the 245.00 TWD price.
Bear case: the Dividend Discount group reads lowest at 25.58 TWD, and 26 of the 26 models stay below the price. Evidence for this calculation is high.
Scenario range: 107.56 TWD (bear) to 266.70 TWD (bull), the price of 245.00 TWD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 63/100 (solid quality), in the Basic Materials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Taiwan Speciality Chemicals Corporation reported revenue of 2.0B TWD in FY2025 versus 516M TWD in FY2021, a compound +40.2%/yr. Reported net income was 620M TWD in FY2025, compounding +33.6%/yr from FY2021.
Key figures
Market cap 40.0B TWD (≈ $1.3B) · P/E ratio 44.5 · P/S ratio 13.8 · EPS (TTM) 5.51 TWD · Dividend yield 1.2% · Net margin 31.1% · Return on equity 24.6% · Return on assets (EBIT) 10.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades about 34% below its 52-week high and 18% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −40% fair-value upside, at −31%, 4772 screens cheaper than that median.
Fair Value models
Bear 107.56 TWDFair Value 169.66 TWDBull 266.70 TWD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (1.84 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+127.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+55.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+36.7%
Start year 2020 (pandemic)
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+33.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+31.8%
Dividend (yield on the price)1.2%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−19% → 43%
2025 sits 180% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Growth Forecast
A lot of optimism in the price
The price assumes about as much growth as the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+37.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+34.0%
Yearly sales growth analysts expect, extended to five years.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about +35.1% a year for the price and +31.9% for the forecasts.
Compare Taiwan Speciality Chemicals Corporation with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 714 stocks
Beats the industry median on 7/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score63 · Top 25%
Fair Value upside−31% · Below median
Profitability
Return on equity (TTM)25% · Top 25%
Return on assets10% · Top 25%
Net margin (TTM)35% · Top 25%
Operating margin (TTM)41% · Top 25%
Growth and dividend
Revenue growth240% · Top 25%
Dividend yield (TTM)1.2% · Below median
Balance sheet
Debt / equity0.53× · Highest 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (TTM)44.5× · Pricier than median
P/B10.76× · Priciest 25%
P/S (TTM)17.27× · Priciest 25%
P/FCF1.7× · Cheaper than median
EV/EBITDA36.2× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 21
PAST (return on equity)99· sector 23
HEALTH (low debt)73· sector 95
DIVIDEND (yield)24· sector 29
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Taiwan Speciality Chemicals Corporation (4772) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 169.66 TWD versus a price of 245.00 TWD, about −31% upside (overvalued).
What is the fair value of 4772?
Our model-based fair value for Taiwan Speciality Chemicals Corporation is 169.66 TWD (as of Sep 24, 2026), built from audited fundamentals. The current price: 245.00 TWD.
What is the quality score of 4772?
Taiwan Speciality Chemicals Corporation has a Quality Score of 63/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Taiwan Speciality Chemicals Corporation (4772)?
Our model-based price target is the fair value of 169.66 TWD (as of Sep 24, 2026) from 26 valuation models. Cautious scenario 107.56 TWD, optimistic scenario 266.70 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Taiwan Speciality Chemicals Corporation stock forecast for 2026?
Our models put fair value at 169.66 TWD, about −31% upside versus a price of 245.00 TWD (overvalued). Cautious scenario 107.56 TWD, optimistic scenario 266.70 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Taiwan Speciality Chemicals Corporation (4772)?
Taiwan Speciality Chemicals Corporation reported trailing-twelve-month revenue of about 2.3B TWD (latest available figure, as of Sep 24, 2026).
Does Taiwan Speciality Chemicals Corporation pay a dividend?
Taiwan Speciality Chemicals Corporation currently shows a dividend yield of about 1.22% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Taiwan Speciality Chemicals Corporation (4772)?
For today's price to be fair in a discounted-cash-flow model, Taiwan Speciality Chemicals Corporation would have to grow free cash flow by +37.2 % per year for five years (discount rate 13.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +36.7 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 4772 use?
Our models discount Taiwan Speciality Chemicals Corporation at 13.1 %: a base by market capitalisation (small), damped by beta 1.45, country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Taiwan Speciality Chemicals Corporation that is +37.2 % per year a year over ten years, using the same discount rate (13.1 %) and the same formula as our fair value.
How much growth has Taiwan Speciality Chemicals Corporation (4772) delivered so far?
Over the past 5 years revenue at Taiwan Speciality Chemicals Corporation grew +36.7 % a year. The price currently implies +37.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Taiwan Speciality Chemicals Corporation (4772) growing?
The median revenue growth in the sector is +0.0 % a year. That is the yardstick for the growth priced into Taiwan Speciality Chemicals Corporation (+37.2 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Taiwan Speciality Chemicals Corporation (4772)?
The free-cash-flow yield on the price is 2.02 %: that much free cash flow Taiwan Speciality Chemicals Corporation produces per unit of market value. When it exceeds the discount rate of our models (13.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Taiwan Speciality Chemicals Corporation (4772)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Taiwan Speciality Chemicals Corporation it is 169.66 TWD per share (as of Sep 24, 2026), against a price of 245.00 TWD. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Taiwan Speciality Chemicals Corporation stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 4772 trades above its calculated fair value: price 245.00 TWD, fair value 169.66 TWD, a gap of about −31% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 4772?
No. The price is what the market pays today (245.00 TWD); the fair value is what the company's own numbers justify (169.66 TWD). For Taiwan Speciality Chemicals Corporation the two are 75.34 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Taiwan Speciality Chemicals Corporation worth?
The market values Taiwan Speciality Chemicals Corporation at about 40.0B TWD (market capitalisation, as of Sep 24, 2026). Per share that is 245.00 TWD; our models calculate a fair value of 169.66 TWD per share.
What do the bullish and bearish scenarios say about 4772?
Our models span a range for Taiwan Speciality Chemicals Corporation: cautious scenario 107.56 TWD, base 169.66 TWD, optimistic 266.70 TWD per share (as of Sep 24, 2026, price 245.00 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 4772?
Taiwan Speciality Chemicals Corporation trades at a price-to-earnings ratio of 44.5 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 169.66 TWD is built from several models across several years. Other multiples: P/B 10.8, P/S 17.3, EV/EBITDA 36.2.
How solid is the balance sheet of Taiwan Speciality Chemicals Corporation (4772)?
Balance-sheet figures for Taiwan Speciality Chemicals Corporation (as of Sep 24, 2026): return on equity 24.6%, debt of 0.53 per unit of equity. They feed the Quality Score of 63/100, which measures business quality independently of the share price.
How far is 4772 from its 52-week high?
Taiwan Speciality Chemicals Corporation trades at 245.00 TWD, about 34% below its 52-week high of 372.01 TWD and 18% above the low of 207.00 TWD (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 169.66 TWD is for.
Which stocks are comparable to Taiwan Speciality Chemicals Corporation?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Taiwan Speciality Chemicals Corporation stock attractive at the current price?
The data as of Sep 24, 2026: price 245.00 TWD, calculated fair value 169.66 TWD (−31%), Quality Score 63/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 4772 calculated?
We run Taiwan Speciality Chemicals Corporation through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 169.66 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Taiwan Speciality Chemicals Corporation itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Taiwan Speciality Chemicals Corporation (4772)?
The closing price on Sep 23, 2026 was 245.00 TWD. Our model-based fair value is 169.66 TWD, about −31% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Taiwan Speciality Chemicals Corporation right now?
Solid but not exceptional quality (63/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (107.56 TWD to 266.70 TWD) leaves room in how you read the outcome.
Key figures of Taiwan Speciality Chemicals Corporation
How large is the market capitalisation of Taiwan Speciality Chemicals Corporation (4772)?
The market capitalisation of Taiwan Speciality Chemicals Corporation is 40.0B TWD (≈ $1.3B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Taiwan Speciality Chemicals Corporation (4772)?
The price-to-sales ratio of Taiwan Speciality Chemicals Corporation is 13.8 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Taiwan Speciality Chemicals Corporation (4772)?
Earnings per share at Taiwan Speciality Chemicals Corporation are 5.51 TWD (price ÷ EPS = P/E 44.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Taiwan Speciality Chemicals Corporation (4772)?
The dividend yield of Taiwan Speciality Chemicals Corporation is 1.2% (payout 54.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Taiwan Speciality Chemicals Corporation (4772)?
The net margin of Taiwan Speciality Chemicals Corporation is 31.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Taiwan Speciality Chemicals Corporation (4772)?
The return on equity (ROE) of Taiwan Speciality Chemicals Corporation is 24.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Taiwan Speciality Chemicals Corporation (4772)?
On an EBIT basis the return on assets of Taiwan Speciality Chemicals Corporation is 10.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Taiwan Speciality Chemicals Corporation (4772)?
The operating margin of Taiwan Speciality Chemicals Corporation is 41.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Taiwan Speciality Chemicals Corporation (4772)?
Revenue at Taiwan Speciality Chemicals Corporation is growing +240% versus a year earlier (3y avg +55.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Taiwan Speciality Chemicals Corporation (4772)?
Earnings per share at Taiwan Speciality Chemicals Corporation are growing +89.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Taiwan Speciality Chemicals Corporation (4772) carry?
The net debt of Taiwan Speciality Chemicals Corporation is 9.5M TWD (fiscal year 2025, ≈ 0.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Taiwan Speciality Chemicals Corporation in the live analysis
One click puts Taiwan Speciality Chemicals Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
